Celsius Holdings (CELH)
NASDAQConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-29
NASDAQConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-29
Research Workspace
Put CELH beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Staples is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Gross margin stays at or above 50% in FY26: Comparison needs review.
View ThesisRevenue growth is accelerating — up about 83% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 61% in its worst 12-month stretch.
View RiskCELH's growth case depends on revenue momentum, though recent revenue growth slowed sharply. Q1 FY2026 revenue grew 138.0% year over year; Q2 growth was 10.6%, with an earnings miss. CELH trades at 43× P/E versus a 16× peer median. The price reflects less growth than our forecast, despite that premium. Gross margin remains the named pillar, but its FY26 comparison needs review. Our model puts the next-quarter miss probability near 25%. Peer multiples imply a price about 24% above where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. CELH is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering CELH (as of Oct 2026).
Based on 11 Wall Street analysts offering 12-month price targets for CELH in the last 4 months.
Continue this research
Compare CELH with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CELH Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Soft Drinks & Non-alcoholic Beverages — fair value, gap to price, and forward P/E.
Compare the value case
Put CELH next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Improve gross margin and operational efficiency
Margin concerns could hinder operational efficiency objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $29.12
The last 12 months of price, then the range of analyst 12-month targets from today’s $29.12.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

CEO share purchases signal confidence in company value.

Threatens: Expand revenue growth through portfolio integration and market expansion
Near-term strain may hinder revenue growth objectives.

Downgrade indicates potential headwinds to revenue growth.

Leadership changes may hinder growth objectives.

Threatens: Expand revenue growth through portfolio integration and market expansion
Nielsen data suggests revenue growth may be slowing.

Texas probe raises legal and valuation concerns.
Advances: Expand revenue growth
New deals indicate strong revenue growth potential.